Usana Health Sciences: Q3 Earnings Insights

Usana Health Sciences USNA reported its Q3 earnings results on Tuesday, October 26, 2021 at 04:17 PM.

Here's what investors need to know about the announcement.

Usana Health Sciences beat their estimated earnings by 4.62%, which did not surprise analysts.

Revenue was up $24,161,000 from the same period last year.

Last quarter the company beat on EPS by $0.16, which was followed by a 0.85% drop in the share price the next day.

Here's a look at Usana Health Sciences's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	1.71	1.48	1.43	1.25
EPS Actual	1.87	1.45	1.87	1.44
Revenue Estimate	332.61M	301.47M	291.54M	277.26M
Revenue Actual	336.84M	307.98M	310.52M	298.51M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Usana Health Sciences management provided guidance for their next quarter, expecting earnings between $1.28 and $1.33 per share for the nextquarter.

This represents a -4.04% in quarter-over-quarter growth for Usana Health Sciences, a bearish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar